Fibrinogen polymorphisms Taq I, Hae III and Bcl I are not associated with a higher risk of deep vein thrombosis

被引：6

作者：

Bozic, M

Teran, N

Peterlin, B

Stegnar, M

机构：

[1] Univ Ljubljana, Med Ctr, Dept Vasc Dis, SI-1525 Ljubljana, Slovenia

[2] Univ Ljubljana, Med Ctr, Dept Obstet & Gynaecol, SI-1525 Ljubljana, Slovenia

来源：

PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS | 2003年 / 33卷 / 03期

关键词：

fibrinogen; venous thrombosis; polymorphism (genetics); aetiology of DVT;

D O I：

10.1159/000077825

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

High fibrinogen is recognised as a risk factor for atherosclerosis. It seems that high fibrinogen is also a risk factor for deep vein thrombosis (DVT). It has been shown that certain polymorphisms in fibrinogen genes can influence the fibrinogen level. In this study, fibrinogen levels and the frequency of the polymorphisms Taq I, Hae III and Bcl I were studied in 114 patients with DVT and 244 healthy subjects. In non-smokers, fibrinogen levels above 5 g/l were associated with an increased risk of DVT (odds ratio 3.3, 95% confidence interval 1.6-7.0). The frequencies of common alleles were similar in patients and healthy subjects for all polymorphisms. An association between fibrinogen levels and the polymorphisms Taq I, Hae III and Bcl I was found in healthy subjects, but not in the patients. It was concluded from these data that the polymorphisms Taq I, Hae III and Bcl I are not major risk factors for DVT. Copyright (C) 2003 S. Karger AG, Basel.

引用

页码：164 / 169

页数：6

共 27 条

[1]

BALLEISEN L, 1985, THROMB HAEMOSTASIS, V54, P475

[2] beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction - The ECTIM study [J].